Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novocure.

Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Glioblastoma

Release Date: September 29, 2017
Expiration Date: September 29, 2018
Media: Internet - based

Activity Overview

Glioblastoma multiforme (GBM) remains one of the most challenging problems to address in all of oncology. Survival outcomes are modest at best, and there have been numerous obstacles to the development of effective strategies to manage GBM. This educational activity has the dual objectives of updating healthcare providers on the latest advances influencing patient care, as well as bringing greater attention to the patient perspective along the continuum of care (eg, screening, diagnosis, information gathering, initiation of treatment, disease progression, eligibility and enrollment in clinical trials, palliation). This will be accomplished through a combination of didactic presentation (featuring audio clips of experts providing their perspectives on the state of the art in GBM management) and a patient panel discussion.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Novocure.

CME/CE Activity Table of Contents

  • Current Treatment Options in Glioblastoma
  • Incorporation of Tumor Treating Fields Into Treatment Paradigms
  • Assessment of Targeted/Antiangiogenic Therapies for Glioblastoma
  • Assessment of Immunotherapy Options for Glioblastoma
  • Case Scenarios
  • Treatment Toxicities and Patient Communication
  • Clinical Trials
  • Patient Panel Discussion Video

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward radiation, surgical, medical and neuro-oncologists, nurse practitioners, nurses, and physician assistants involved in the treatment and management of patients with GBM. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of GBM may also participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:

  • Discuss current and emerging evidence concerning strategies and technologies for the treatment and management of patients with GBM
  • Explain the mechanism of action of therapies and technologies that have been applied to the management of GBM
  • Apply practical aspects related to integrating Tumor Treating Field therapy and other novel approaches into evolving treatment paradigms for patients with GBM
  • Incorporate skills that promote effective communication and coordination of care between the provider and the patient/caregiver in the management of GBM

Faculty, Staff, and Planners' Disclosures


David A. Reardon, MD
Professor of Medicine, Harvard Medical School
Clinical Director, Center for Neuro-Oncology
Dana-Farber Cancer Institute
Boston, MA

Disclosure: Grant/Research Support: Celldex Therapeutics, Incyte, Midatech, Acerta Pharma, Agenus, EMD Serono, Inovio, Tragara. Consultant: AbbVie, Agenus, Amgen, BMS, Cavion, Celldex, EMD Serono, Genentech/Roche, Inovio, Juno Pharmaceuticals, Merck, Midatech, Momenta Pharmaceuticals, Novartis, Novocure, Oxigene, Regeneron, Stemline Therapeutics. Speakers Bureau: BMS, Genentech/Roche, Merck


Timothy Cloughesy, MD
Professor and Director
UCLA Neuro-Oncology Program
Department of Neurology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosure: Consultant: VBL, Insys, Roche, Human Longevity, Sunovion, Boston Biomedical, Alexion, Wellcome Trust, Novogen, Novocure, Tocagen, BMS, AbbVie, GW Pharma, Cortice

Rimas V Lukas, MD
Associate Chief, Neuro-Oncology Division
Feinberg School of Medicine, Northwestern Medicine
Chicago, Il

Disclosure: AbbVie, AstraZeneca, ZIOPHARM, Arbor Pharmaceuticals. Meeting, travel to present research: Roche.

Sandra Ruland, RN, BSN, OCN
Program Nurse, Neuro-Oncology
Dana-Farber Cancer Institute
Boston, MA

Disclosure: No relevant financial relationships with commercial interests to disclose

Connie Etheridge (Patient Interviewee)
Ben Etheridge (Caregiver Interviewee)

Connie Etheridge and Ben Etheridge have no relevant financial relationships with commercial interests to disclose.

The following individuals have no relevant financial relationships with commercial interests:
The staff of PER®.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

CME/CE Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
Toll-Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Become a Member

Forgot Password?
Filter By